Managing Associate

Ryan Lim

ryan.lim@sidley.com

シンガポール +65 6230 3934

- Letter
- A4

RYAN LIM’s practice focuses on mergers and acquisitions, private equity, joint ventures, solvent corporate restructuring, and corporate advisory work. He has experience in representing a diverse range of clients on acquisitions, buyouts, and majority and minority investments across Asia in a variety of industries, including technology and healthcare.

Prior to joining Sidley, Ryan worked at a leading Southeast Asia law firm.

Ryan is fluent in English and Chinese.

経験

Stonepeak on its preferred equity investment into AGP Sustainable Real Assets, a Singapore-based global infrastructure and real assets developer and operator, whose assets include data centers.
Xenith IG, a dark fibre network infrastructure platform jointly established by DigitalBridge Group and Columbia Capital, on its acquisitions in Indonesia and Malaysia.
KKR on its investment into GrowSari (Series C; a B2B e-commerce platform in the Philippines).
ChrysCapital, a leading investment firm in India on its acquisition of Results CX, a customer experience company working with Fortune 100 and 500 companies worldwide, from One Equity Partners.
Hillhouse Capital on its bid to acquire Eu Yang Sang, one of the leading traditional Chinese medicine retailer and manufacturers in Asia.
Jungle Ventures, CerraCap Ventures and CapHorn on the sale of Dathena Science, a Singapore-headquartered deep-tech company that provides AI driven data privacy and security solutions, to Proofpoint.
Rainmaking on the sale of its Asia Pacific venture-building and start-up business, comprising operations across Singapore, Japan and South Korea, to consulting firm Bain & Company.
A Singapore-based leading telecommunications company on its successful disposal of a cyber security firm, to an indirect subsidiary of a global investment company headquartered in Singapore, for approximately S$133 million.
A Japanese-based multinational conglomerate on its successful acquisition of a Big Data and AI technology market leader in the Asian region.
A Japanese-listed diversified company on its successful minority investment in a Singapore-based flavors company with businesses in Singapore, Indonesia, Malaysia, and Thailand.
EDBI, the investment arm of the Singapore Economic Development Board, in its Series A investment in Automera, a company developing an autophagy drug designed to target chimera small molecules (AUTACs).

*Includes matters completed prior to joining Sidley.

Law Society of Singapore
Singapore Academy of Law

資格

弁護士資格・登録

Singapore (Advocate & Solicitor)

学歴

Singapore Management University, 法学学士, 2017 (magna cum laude)